POINT Biopharma Global Inc.

POINT Biopharma Global Inc.verified

PNT

Price:

$12.5

Market Cap:

$1.33B

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast...[Read more]

Industry

Biotechnology

IPO Date

2020-07-08

Stock Exchange

NASDAQ

Ticker

PNT

The ROE as of December 2024 (TTM) for POINT Biopharma Global Inc. (PNT) is -11.52%

According to POINT Biopharma Global Inc.’s latest financial reports and current stock price. The company's current ROE is -11.52%. This represents a change of -348.91% compared to the average of 4.63% of the last 4 quarters.

POINT Biopharma Global Inc. (PNT) Historical ROE (quarterly & annually)

How has PNT ROE performed in the past?

The mean historical ROE of POINT Biopharma Global Inc. over the last ten years is 75.75%. The current -11.52% ROE has changed -115.20% with respect to the historical average. Over the past ten years (40 quarters), PNT's ROE was at its highest in in the December 2022 quarter at 33.53%. The ROE was at its lowest in in the December 2020 quarter at -41.18%.

Quarterly (TTM)
Annual

Average

75.75%

Median

1.10%

Minimum

-99.20%

Maximum

400.00%

POINT Biopharma Global Inc. (PNT) ROE by Quarter and Year

Discovering the peaks and valleys of POINT Biopharma Global Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 400.00%

Minimum Annual Increase = -212.23%

Minimum Annual ROE = -99.20%

Quarterly (TTM)
Annual
YearROEChange
202220.19%-212.23%
2021-17.99%-81.87%
2020-99.20%-124.80%

POINT Biopharma Global Inc. (PNT) Average ROE

How has PNT ROE performed in the past?

The current ROE of POINT Biopharma Global Inc. (PNT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-32.33%

5-year avg

75.75%

10-year avg

75.75%

POINT Biopharma Global Inc. (PNT) ROE vs. Peers

How is PNT’s ROE compared to its peers?

POINT Biopharma Global Inc.’s ROE is greater than ORIC Pharmaceuticals, Inc. (-42.46%), greater than Lyra Therapeutics, Inc. (-178.68%), less than Inhibrx Biosciences, Inc. (1.45%), greater than ESSA Pharma Inc. (-21.64%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than ALX Oncology Holdings Inc. (-93.02%), greater than Immatics N.V. (-15.98%), greater than BioAtla, Inc. (-187.30%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than RAPT Therapeutics, Inc. (-89.09%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than Pardes Biosciences, Inc. (-41.86%), greater than Third Harmonic Bio, Inc. (-14.46%), greater than PMV Pharmaceuticals, Inc. (-24.20%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Enochian Biosciences, Inc. (-73.71%), greater than Revolution Medicines, Inc. (-33.67%), greater than NewAmsterdam Pharma Company N.V. (-53.79%), greater than Centessa Pharmaceuticals plc (-52.22%), greater than Sutro Biopharma, Inc. (-97.01%), less than Opthea Limited (398.06%), greater than HilleVax, Inc. (-67.27%),

Build a custom stock screener for POINT Biopharma Global Inc. (PNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like POINT Biopharma Global Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

POINT Biopharma Global Inc. (PNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like POINT Biopharma Global Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is POINT Biopharma Global Inc.'s ROE?

How is the ROE calculated for POINT Biopharma Global Inc. (PNT)?

What is the highest ROE for POINT Biopharma Global Inc. (PNT)?

What is the 3-year average ROE for POINT Biopharma Global Inc. (PNT)?

What is the 5-year average ROE for POINT Biopharma Global Inc. (PNT)?

How does the current ROE for POINT Biopharma Global Inc. (PNT) compare to its historical average?